期刊文献+

伏立康唑致严重肝损害1例 被引量:10

Serious liver damage caused by voriconazole in one case
原文传递
导出
摘要 1例81岁男性患者,因肺丝状真菌感染,静滴伏立康唑粉针200 mg,Q12h。治疗3 d后,出现肝损害;后改为伏立康唑片口服100 mg,Q12h,序贯抗真菌,并加用异甘草酸镁注射液150 mg、Qd及复合辅酶粉针等降酶保肝治疗。7 d后,因药物引起肝损害进行性加重,停用伏立康唑;但肝损害继续恶化,致多脏器功能衰竭。 A 81 years old male patient with pulmonary filamentous fungal infections, treated with voriconazole injection 200 mg, Q12 h, liver damage occurred after 3 days voriconazole injection used. Hence, voriconazole injection was replaced with voriconazole pills, and treated with Magnesum Isoglycyrrhizinate injection, Coenzyme Complex injection for improving liver function. Unfortunately, the patient liver damage worsened seriously companied multiple organs dysfunction after 7 days the drug used.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2013年第10期795-796,共2页 The Chinese Journal of Clinical Pharmacology
关键词 伏立康唑 药物不良反应 肝损害 voriconazole adverse drugs reaction liver damage
  • 相关文献

参考文献3

二级参考文献39

  • 1黄成坷,邱相君,胡国新,代宗顺.伏立康唑分散片人体生物等效性研究[J].中国药学杂志,2007,42(16):1241-1243. 被引量:13
  • 2Purkins L, Wood N al. Voriconazole Kleinermans D, et potentiates warfarininduced prothrombin time prolongation[ J ]. Br J Clin Pharmacol, 2003,56 (Suppl 1 ) : 24-29.
  • 3Saari T I, Laine K, Leino K, et al. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life [J]. Clin Pharmacol Ther, 2006,80(5 ) : 502-508.
  • 4Saari T I, Laine K, Bertilsson L, et al. Voriconazole and fluconazole increase the exposure to oral diazepam [J]. Eur J Clin Pharmacol, 2007,63 (10) : 941-949.
  • 5Saari T I, Laine K, Neuvonen M, et al. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl [J]. Eur J Clin Pharmacol,2008, 64( 1 ) :25-30.
  • 6Wood N, Tan K, Purkins L, et al. Effect of omeprazole on the steady-state pharmacokineticsofvoriconazole [J]. BrJ Clin Pharmacol, 2003,56( Suppl 1 ) : 56-61.
  • 7Wood N, Tan K, Allan R, et al. Effect of vorieonazole on the pharmacokinetics of omeprazole [Z]. Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother, 2001, 16(19) :41.
  • 8Liu P, Foster G, Labadie R R, et al. Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects [J]. J Clin Pharmacol, 2008,48( 1 ) :73-84.
  • 9Purkins L, Wood N, Ghahramani P, et al. Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration [J]. Br J Clin Pharmacol, 2003,56( Suppl 1 ) : 37-44.
  • 10Purkins L, Wood N, Kleinermans D, et al. No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers [J]. Br J Clin Pharmacol, 2003,56 (Suppl 1 ) : 62-68.

共引文献43

同被引文献125

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部